Healthcare Industry News: Valeant
News Release - January 2, 2009
Valeant Pharmaceuticals Completes Acquisition of Dow Pharmaceutical Sciences, Inc.
ALISO VIEJO, Calif., Jan. 2 (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International (NYSE: VRX ) today announced that effective December 31, 2008, the company completed its acquisition of Dow Pharmaceutical Sciences, Inc., a privately held dermatology company that specializes in the development of topical products on a proprietary basis, as well as for pharmaceutical and biotechnology companies.About Valeant
Valeant Pharmaceuticals International (NYSE: VRX ) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.Valeant.com.
Source: Valeant Pharmaceuticals
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!